Literature DB >> 33555434

Short-term changes and correlations of plasma spexin, kisspeptin, and galanin levels after laparoscopic sleeve gastrectomy.

Mustafa Atabey1, Muhammed Raşid Aykota2, Mehmet İlker Özel3, Gökhan Arslan4.   

Abstract

PURPOSE: To determine the circulating levels of spexin, kisspeptin, galanin, and the correlations between these peptides after laparoscopic sleeve gastrectomy (LSG).
METHODS: The plasma levels of the spexin, kisspeptin, and galanin and metabolic parameters (body mass index, weight loss, % excess weight loss, body fat, fasting glucose, HbA1C, and cholesterol levels) were measured (baseline, 1 month, and 3 months) and correlated in thirty adult individuals with obesity (22 female and 8 male) after LSG.
RESULTS: The body mass index (BMI), body fat, fasting glucose, total and low-density lipoprotein cholesterol decreased, while high-density lipoprotein cholesterol and % EWL (excess weight loss) increased at 3 months after surgery. The plasma spexin levels increased at 3 months, kisspeptin levels increased at 1 month and stabilized afterward, and galanin levels decreased at 3 months after LSG. Significant correlations were found between metabolic parameters with spexin, kisspeptin, and galanin. In addition, spexin and kisspeptin were negatively correlated with galanin, while spexin was positively correlated with kisspeptin.
CONCLUSIONS: The biochemical data reveal evidence that LSG causes an increase in the levels of spexin, and kisspeptin and a decrease in galanin levels. Our findings, therefore, suggest a possible interaction between these novel peptides, which have potential roles in obesity and glucose metabolism.

Entities:  

Keywords:  Galanin; Kisspeptin; LSG; Obesity; Obesity surgery; Sleeve gastrectomy; Spexin

Year:  2021        PMID: 33555434     DOI: 10.1007/s00595-021-02240-6

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  36 in total

Review 1.  Long-term weight loss maintenance.

Authors:  Rena R Wing; Suzanne Phelan
Journal:  Am J Clin Nutr       Date:  2005-07       Impact factor: 7.045

2.  Association between obesity and psychiatric disorders in the US adult population.

Authors:  Gregory E Simon; Michael Von Korff; Kathleen Saunders; Diana L Miglioretti; Paul K Crane; Gerald van Belle; Ronald C Kessler
Journal:  Arch Gen Psychiatry       Date:  2006-07

3.  Roux-en-Y gastric bypass surgery in youth with severe obesity: 1-year longitudinal changes in spexin.

Authors:  Seema Kumar; Md Jobayer Hossain; Thomas Inge; P Babu Balagopal
Journal:  Surg Obes Relat Dis       Date:  2018-07-20       Impact factor: 4.734

Review 4.  Sleeve gastrectomy: have we finally found the holy grail of bariatric surgery? A review of the literature.

Authors:  I Kehagias; A Zygomalas; D Karavias; S Karamanakos
Journal:  Eur Rev Med Pharmacol Sci       Date:  2016-12       Impact factor: 3.507

5.  A two-year randomized trial of obesity treatment in primary care practice.

Authors:  Thomas A Wadden; Sheri Volger; David B Sarwer; Marion L Vetter; Adam G Tsai; Robert I Berkowitz; Shiriki Kumanyika; Kathryn H Schmitz; Lisa K Diewald; Ronald Barg; Jesse Chittams; Reneé H Moore
Journal:  N Engl J Med       Date:  2011-11-14       Impact factor: 91.245

6.  Regulation of Hepatocellular Fatty Acid Uptake in Mouse Models of Fatty Liver Disease with and without Functional Leptin Signaling: Roles of NfKB and SREBP-1C and the Effects of Spexin.

Authors:  Jasmine F Ge; J L Walewski; D Anglade; P D Berk
Journal:  Semin Liver Dis       Date:  2016-12-20       Impact factor: 6.115

7.  Coevolution of the spexin/galanin/kisspeptin family: Spexin activates galanin receptor type II and III.

Authors:  Dong-Kyu Kim; Seongsik Yun; Gi Hoon Son; Jong-Ik Hwang; Cho Rong Park; Jae Il Kim; Kyungjin Kim; Hubert Vaudry; Jae Young Seong
Journal:  Endocrinology       Date:  2014-02-11       Impact factor: 4.736

Review 8.  The Complex Interactions Between Obesity, Metabolism and the Brain.

Authors:  Romina María Uranga; Jeffrey Neil Keller
Journal:  Front Neurosci       Date:  2019-05-24       Impact factor: 4.677

Review 9.  The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis.

Authors:  Daphne P Guh; Wei Zhang; Nick Bansback; Zubin Amarsi; C Laird Birmingham; Aslam H Anis
Journal:  BMC Public Health       Date:  2009-03-25       Impact factor: 3.295

10.  Spexin is a novel human peptide that reduces adipocyte uptake of long chain fatty acids and causes weight loss in rodents with diet-induced obesity.

Authors:  José L Walewski; Fengxia Ge; Harrison Lobdell; Nancy Levin; Gary J Schwartz; Joseph R Vasselli; Afons Pomp; Gregory Dakin; Paul D Berk
Journal:  Obesity (Silver Spring)       Date:  2014-03-08       Impact factor: 5.002

View more
  2 in total

Review 1.  Impact of spexin on metabolic diseases and inflammation: An updated minireview.

Authors:  İbrahim Türkel; Gülsün Memi; Burak Yazgan
Journal:  Exp Biol Med (Maywood)       Date:  2022-01-22

2.  Circulating Spexin Is Associated with Body Mass Index and Fat Mass but Not with Physical Activity and Psychological Parameters in Women across a Broad Body Weight Spectrum.

Authors:  Maria Suhs; Andreas Stengel; Amelie Rudolph; Selina Schaper; Ellen Wölk; Peter Kobelt; Matthias Rose; Tobias Hofmann
Journal:  J Clin Med       Date:  2022-08-30       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.